Drug Development Solutions
-
Accelerate Molecules Through Development With Translational Pharmaceutics®
3/17/2025
By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.
-
Early Developability Assessment For Smarter Antibody Selection
1/21/2026
Integrated laboratory and in‑silico developability assessments provide early insight into antibody characteristics, reduce risks, streamline decision‑making, and accelerate progress from discovery toward successful drug product development.
-
A Scalable, Benchtop Mixing System For Sensitive Fluids
11/3/2025
Examine a scalable, benchtop mixing system designed for sensitive fluids and GxP environments that supports automated control, traceability, and compliance from early development through production.
-
Microbial CDMO Services
With over 30+ years’ of experience in microbial CDMO services, one of our core areas of expertise is the development of large-scale processes for recombinant protein expression in microbial hosts (E.coli, P.pastoris and S.cerevisiae).
-
PBPK Predictive Modeling Services
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
-
Cell & Gene Therapy Testing
9/11/2024
Cell and Gene Therapies hold immense potential for revolutionizing healthcare. However, ensuring the safety and efficacy of these therapies is paramount. Learn how the right partner can empower you to unlock the full potential of your CGT.
-
Crystallization Engineering
3/11/2026
Explore how structure‑guided crystallization, solvent screening, and PAT optimization improve particle control, accelerate development, and enhance scalability while tackling yield and purity issues.
-
From Discovery To Delivery: A Smarter Path For Scaling Biologics
4/8/2026
A unified global model streamlines biologics from discovery to commercial supply, integrating development, manufacturing, advanced modalities, and flexible partnerships worldwide.
-
Powering Gene Therapy Progress With High-Performance Lentiviral Vectors
5/7/2025
Accelerate your gene therapy pipeline with our cost-effective, high-quality lentiviral vectors, optimized for clinical and commercial success.
-
Formulation Development: Navigate The Complex Concept-To-Market Path
7/11/2024
By leveraging cutting-edge technological advancements, researchers can optimize formulations in terms of solubility, delivery method, safety profile, and sustained stability.